![Mac Taketani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Mac Taketani currently works at CarbGeM Inc., as Chief Business Officer.
Actieve functies van Mac Taketani
Bedrijven | Functie | Begin |
---|---|---|
CarbGeM Inc.
![]() CarbGeM Inc. Miscellaneous Commercial ServicesCommercial Services CarbGeM Inc. is a Japanese company that aims to protect humanity from the threat of bacterial infections and realize a safer world. The company is based in Shibuya-ku, Japan. The company focuses on solving infectious diseases and drug resistance issues through next-generation AI medical innovation using AI image analysis technology. The company aims to build seeds and product development platforms in the life science field through research and development of next-generation technology related to the infectious disease field. The company has developed a point of care automatic gram dye called "Bitte" that can provide doctors and laboratory technicians with estimates of bacterial infections and help them select appropriate antibiotics. The company was founded in 2016 by Masakazu Nakajima, who has been the CEO since then. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
CarbGeM Inc.
![]() CarbGeM Inc. Miscellaneous Commercial ServicesCommercial Services CarbGeM Inc. is a Japanese company that aims to protect humanity from the threat of bacterial infections and realize a safer world. The company is based in Shibuya-ku, Japan. The company focuses on solving infectious diseases and drug resistance issues through next-generation AI medical innovation using AI image analysis technology. The company aims to build seeds and product development platforms in the life science field through research and development of next-generation technology related to the infectious disease field. The company has developed a point of care automatic gram dye called "Bitte" that can provide doctors and laboratory technicians with estimates of bacterial infections and help them select appropriate antibiotics. The company was founded in 2016 by Masakazu Nakajima, who has been the CEO since then. | Commercial Services |